Cargando…
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
The nature of the inflammatory and fibrotic processes found in patients with post-COVID-19 syndrome makes it possible to speculate that in such patients fractional exhaled nitric oxide (FeNO) may be a useful biomarker. Consequently, we set out to verify the consistency of this hypothesis. We consecu...
Autores principales: | Maniscalco, Mauro, Ambrosino, Pasquale, Poto, Remo, Fuschillo, Salvatore, Poto, Sergio, Matera, Maria Gabriella, Cazzola, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789557/ https://www.ncbi.nlm.nih.gov/pubmed/35114576 http://dx.doi.org/10.1016/j.rmed.2022.106745 |
Ejemplares similares
-
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation
por: Maniscalco, Mauro, et al.
Publicado: (2021) -
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients
por: Maniscalco, Mauro, et al.
Publicado: (2021) -
Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
por: Ambrosino, Pasquale, et al.
Publicado: (2022) -
Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients
por: Maniscalco, Mauro, et al.
Publicado: (2022) -
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings
por: Fuschillo, Salvatore, et al.
Publicado: (2021)